Understanding QIDP and Other 21st Century Incentives for Developing and Marketing Anti-Infectives: “A New Class of Antimicrobials—The HDP Mimetics” May 21, 2015 ·
25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2015): “A Randomized, Double-Blind Study Comparing Single-Dose and Short-Course Brilacidin... April 27, 2015 ·
25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2015): “Brilacidin, Host Defense Peptide Mimetic, One of a New Class of Immunomodulatory... April 26, 2015 ·
25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2015): “Synthetic Novel Host Defense Protein Mimetics for the Treatment of Gram-Negative Bacterial Infections” April 26, 2015 ·
2013 Elsevier Therapeutic Area Partnership (TAP): “Infectious Diseases: Top Projects to Watch” November 19, 2013 ·
23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2013): “Use of Pharmacokinetics-Pharmacodynamics and Monte Carlo Simulation Analyses to Support Brilacidin... April 19, 2013 ·
23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2013): “Population Pharmacokinetic Analyses of Brilacidin Using Data from Patients with ABSSSI” April 19, 2013 ·
23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2013): “Pharmacokinetic-Pharmacodynamic Analyses for Efficacy and Safety of Brilacidin... April 19, 2013 ·